 compared to other treatments. When they compared specific combinations such as sulfonylureas and insulin with the newer medications, SGLT2s and GLP-1s for a side effect of interest, severe hyperglycemia, they found that these newer medications also significantly reduced hyperglycemia, not unexpected.